Minerva Neurosciences stockholders approve increase in authorized common shares to 250M and 12.5M new equity plan shares

Minerva Neurosciences, Inc.

Stockholders approved increasing authorized common shares from 125M to 250M. Votes: 4,917,181 for, 314,773 against.
Approved amendment to 2013 Equity Plan adding 12,500,000 shares for issuance under the plan. Votes: 3,653,490 for, 32,045 against.
Elected Fouzia Laghrissi-Thode and Inderjit Kaul as directors with 3,502,340 and 3,650,817 votes for, respectively.
Approved issuance of common shares upon conversion of Series A Preferred Stock. Votes: 2,909,574 for, 114,818 against.
Ratified Deloitte & Touche as independent auditor for FY2025 with 5,152,013 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.